Cardiology – Page 6

Cardiovascular Prevention Among Healthcare Professionals: Insights from the ESC Congress Cardiovascular Health Check 2025

By MedXY 09/01/2026

Healthcare professionals face significant gaps in cardiovascular prevention despite their critical role in care. The ESC Congress 2025 revealed prevalent modifiable risks, underuse of therapies, and subclinical atherosclerosis, underscoring urgent needs for tailored implementation strategies.

Cardiology news

Vutrisiran and Tafamidis in Transthyretin Amyloidosis Cardiomyopathy: Evaluating Combination Therapy Insights from HELIOS-B

By MedXY 09/01/2026

The HELIOS-B trial showed vutrisiran improves survival and cardiac outcomes in transthyretin amyloidosis with cardiomyopathy, with consistent benefits regardless of baseline tafamidis use, supporting further evaluation of combination therapy.

Cardiology Clinical Updates news

Short-Term Anticoagulant Therapy and Subclinical Leaflet Thickening in Transcatheter Aortic Valves: Evidence and Insights from the NOTION-4 Trial

By MedXY 09/01/2026

The NOTION-4 trial demonstrates that 3 months of DOAC therapy post-TAVR reduces early HALT incidence compared to SAPT, but benefits diminish after discontinuation, highlighting nuanced balance between thrombosis prevention and bleeding risk in anticoagulation strategies.

Cardiology news Nursing & care

Improving Heart Failure Outcomes in India: Evidence from the TIME-HF Nurse-Coordinated, Digital-Supported Care Model Trial

By MedXY 09/01/2026

A nurse-led, mobile health-supported collaborative care intervention significantly increased days alive and out of hospital and reduced mortality among Indian patients with heart failure with reduced ejection fraction over 2 years.

Cardiology news

Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Risk Across the Adult Lifespan: Insights from a Large Population Study

By MedXY 09/01/2026

Elevated lipoprotein(a) confers a consistent relative risk increase for atherosclerotic cardiovascular disease across all adult ages, with absolute risks rising substantially in older adults.

Cardiology General Surgery news

Optimal Early Outcomes in Acute Type A Aortic Dissection Repair: Prioritizing Adequate Perfusion Over Cannulation Strategy

By MedXY 08/31/2026

This study shows that the choice of cannulation site—femoral versus axillary—does not independently affect early mortality or neurological complications after acute type A aortic dissection repair; instead, timely systemic reperfusion and control of shock are critical.

Cardiology news

Global Insights on Implantable Cardioverter-Defibrillators in High-Risk Hypertrophic Cardiomyopathy: Efficacy and Outcomes

By MedXY 08/31/2026

An international multicenter study shows ICDs effectively prevent sudden death in high-risk hypertrophic cardiomyopathy patients, demonstrating low mortality rates and significant lifesaving interventions over long-term follow-up.

Cardiology Neurology news

RNF213 p.R4810K Variant: A Novel Independent Genetic Risk Factor for Extracranial Carotid Artery Disease

By MedXY 08/30/2026

The RNF213 p.R4810K variant independently increases risk and severity of extracranial carotid artery disease, distinct from its known association with intracranial atherosclerosis, highlighting new insights into vascular disease genetics and stroke risk assessment.

AI Cardiology news

Revolutionizing Aortic Stenosis Screening: AI-Enabled Focused Cardiac Ultrasound with Novice Operators

By MedXY 08/30/2026

A novel deep learning algorithm accurately detects moderate or greater aortic stenosis using AI-guided focused cardiac ultrasound acquired by novice operators, presenting a scalable solution to expand screening accessibility.

Cardiology news

Advancing Prognostication in Transthyretin Amyloid Cardiomyopathy: A Machine Learning Risk Prediction Model

By MedXY 08/30/2026

A novel machine learning-based model demonstrates improved risk prediction in transthyretin amyloid cardiomyopathy, surpassing traditional staging systems and supporting personalized patient management.

Cardiology news

Evolving Impact of Implantable Cardioverter-Defibrillators on Mortality Post-Myocardial Infarction: Insights from the PROFID Study

By MedXY 08/30/2026

The PROFID study reveals a declining mortality benefit from primary prevention implantable cardioverter-defibrillators in post-myocardial infarction patients with reduced ejection fraction over recent decades, highlighting changing clinical landscapes.

Cardiology news

Bridging the Gap: ESC Prevention and Cardiac Rehabilitation Recommendations and What EUROASPIRE VI Reveals About Reality in Europe

By MedXY 08/30/2026

EUROASPIRE VI exposes wide gaps between ESC prevention and cardiac rehabilitation recommendations and everyday care across Europe — especially in high-risk regions. This article distills core guideline recommendations, what's new, and how clinicians and systems can close the gap.

Cardiology news

Sustained Cardiovascular Protection With Evolocumab in Patients Without Prior MI or Stroke: Insights From the VESALIUS-CV Trial

By MedXY 08/30/2026

Evolocumab significantly reduces first and subsequent major adverse cardiovascular events in high-risk patients without prior myocardial infarction or stroke, affirming the benefit of intensive LDL-C lowering for cumulative cardiovascular risk reduction.

Cardiology news Pediatrics

Low Ventricular Chamber Stiffness as a Marker of High-Risk Eccentric Remodeling in Fontan Circulation: Insights from the FORCE Registry

By MedXY 08/30/2026

Lower ventricular chamber stiffness predicts adverse outcomes in Fontan patients, revealing a high-compliance, eccentric remodeling phenotype distinct from traditional stiffening hypotheses.

Cardiology news Public Health

Sustained Cardiovascular Benefits of Intensive Blood Pressure Management Led by Nonphysician Providers: 7-Year Follow-Up of the CRHCP Trial

By MedXY 08/30/2026

Long-term intensive BP control led by trained nonphysician community providers significantly lowers cardiovascular risk over 7 years, with benefits persisting 3 years post-intervention in rural China.

Cardiology Hematology-Oncology news

Plasma Biomarkers CPVL and PIGR Predict Anthracycline-Induced Cardiotoxicity in Hematologic Cancer Patients

By MedXY 08/28/2026

Baseline plasma levels of CPVL and PIGR correlate with anthracycline-induced systolic dysfunction, offering potential early biomarkers for cardiotoxicity in hematologic malignancy patients undergoing chemotherapy.

Cardiology Internal Medicine news

Sex-Specific Skeletal Muscle Inflammation and Dysfunction in Heart Failure with Reduced Ejection Fraction

By MedXY 08/28/2026

This study reveals distinct sex differences in skeletal muscle inflammation and dysfunction in patients with HFrEF, highlighting divergent immune cell profiles linked to muscle mass and strength variations in men versus women, advancing understanding of HF symptom disparities.

Cardiology Clinical Updates news

Myocardial Fibrosis and Reverse Remodeling After Valve Replacement in Chronic Aortic Regurgitation: Advances and Clinical Implications

By MedXY 08/28/2026

This review synthesizes current evidence on myocardial fibrosis and ventricular remodeling after AVR in chronic AR, highlighting imaging biomarkers, remodeling patterns, and functional outcomes relevant to clinical practice.

Cardiology Clinical Updates news

Right Ventricular Function, Clinical Outcomes, and Effect of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: Insights from the HELIOS-B Trial

By MedXY 08/28/2026

This review synthesizes evidence on the prevalence and prognostic value of right ventricular dysfunction in ATTR-CM and the therapeutic impact of vutrisiran on RV function from the HELIOS-B trial, underscoring RV free wall strain as a key biomarker and treatment target.

Cardiology news

Harnessing the Vagus Nerve: A Novel Frontier in Myocardial Infarction Management

By MedXY 08/28/2026

This article explores the vital role of the vagus nerve in modulating myocardial infarction outcomes through autonomic regulation, reflex pathways, and cardioprotective mechanisms, highlighting translational potential from experimental models to clinical interventions.